# INVOKAMET
> **NDA204353** · New Drug Application · Sponsor: JANSSEN PHARMS · Approved 2014-08-08
## Drug
- **FDA Application Number:** NDA204353
- **Application type:** New Drug Application
- **Brand name:** INVOKAMET
- **Generic name:** CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE
- **Active ingredients:** CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** JANSSEN PHARMS
- **Manufacturer:** Janssen Pharmaceuticals, Inc.
- **First approval:** 2014-08-08
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204353)
---
*AI Analytics · CC0 1.0*